R. P. Scherer Corp. deal

R. P. Scherer Corp. (SHR) R. P. Scherer and Eli Lilly and Co. will develop formulations of an undisclosed chemical entity using SHR's Zydis oral fast dissolving dosage form. Lilly will pay SHR (Troy...